Merck to pay additional $58M for Vioxx
Pharma Compliance Alert, May 28, 2008
Merck’s costs for the withdrawn painkiller Vioxx continue to mount.
Earlier this year, Merck proposed a $4.85 billion settlement with patients who claim they were harmed by Vioxx. Last week, the company agreed to pay $58 million to settle claims by 29 states and the District of Columbia that it downplayed the risks of Vioxx in advertising, according to a press release from Pennsylvania Attorney General Tom Corbett.
As part of the settlement, Merck will submit all television ads to the FDA for review before airing them for the next seven years and will follow all of the FDA’s proposed changes. Merck will also no longer engage in ghostwriting and will not use scientific data deceptively when marketing to physicians.
Comments
0 comments on “Merck to pay additional $58M for Vioxx ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched